认知功能与肾移植候选者的移植准入及等待期死亡率:糖尿病与非糖尿病的差异
该前瞻性队列研究纳入3630例肾移植评估候选者,用3MS评估认知功能,发现6.4%存在认知障碍;认知障碍独立关联 listing 机会降低25%(aHR 0.75,95%CI 0.61-0.91),且该关联不因糖尿病状态而异(P交互=0.07)。在无糖尿病候选者中,认知障碍与等待期死亡率升高相关(sHR 2.47,95%CI 1.31-4.66),而在糖尿病候选者中无此关联。
要点
- 肾移植评估时6.4%候选者存在认知障碍(3MS<80)。
- 认知障碍独立降低 listing 机会25%(aHR 0.75)。
- 无糖尿病者认知障碍与等待期死亡率升高相关(sHR 2.47)。
核心结论
- 认知障碍与肾移植等待名单登记机会降低独立相关。
- 在无糖尿病的候选者中,认知障碍与等待期死亡率升高相关;在糖尿病候选者中未观察到该关联。
研究设计与样本
- 前瞻性队列研究,纳入2009年1月至2018年6月在2个移植中心评估的3630例候选者。
- 认知功能采用简易智力状态检查修改版(3MS)测量,认知障碍定义为3MS评分<80。
主要发现
- 评估时6.4%的参与者存在认知障碍。
- 认知障碍与 listing 机会降低25%独立相关(aHR 0.75,95%CI 0.61-0.91),该关联不因糖尿病状态而异(P交互=0.07)。
- 认知障碍与移植率关联的糖尿病交互作用P=0.05,与等待期死亡率关联的糖尿病交互作用P=0.02。
- 无糖尿病候选者中,认知障碍者等待期死亡风险为2.47倍(95%CI 1.31-4.66);糖尿病候选者中无此关联。
关键数值与推荐
- 认知障碍定义为3MS评分<80。
- 调整后 listing 风险比0.75(95%CI 0.61-0.91)。
- 无糖尿病者等待期死亡风险比2.47(95%CI 1.31-4.66)。
临床怎么用
- 肾移植评估时可考虑筛查轻度认知障碍,以识别 listing 机会较低和等待期死亡风险较高的候选者。
- 对无糖尿病的认知障碍候选者,应关注等待期死亡风险并加强随访管理。
局限性
- 认知障碍仅单次测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Intact cognition is generally a prerequisite for navigating through and completing evaluation for kidney transplantation. Despite kidney transplantation being contraindicated for those with severe dementia, screening for more mild forms of cognitive impairment before referral is rare. Candidates may have unrecognized cognitive impairment, which may prolong evaluation, elevate mortality risk, and hinder access to kidney transplantation. We estimated the burden of cognitive impairment and its association with access to kidney transplantation and waitlist mortality. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 3,630 participants (January 2009 to June 2018) with cognitive function measured (by the Modified Mini-Mental State Examination [3MS]) at kidney transplantation evaluation at 1 of 2 transplantation centers. PREDICTORS: Cognitive impairment (3MS score<80). OUTCOMES: Listing, waitlist mortality, and kidney transplantation. ANALYTICAL APPROACH: We estimated the adjusted chance of listing (Cox regression), risk for waitlist mortality (competing-risks regression), and kidney transplantation rate (Poisson regression) by cognitive impairment. Given potential differences in cause of cognitive impairment among those with and without diabetes, we tested whether these associations differed by diabetes status using a Wald test. RESULTS: At evaluation, 6.4% of participants had cognitive impairment, which was independently associated with 25% lower chance of listing (adjusted HR, 0.75; 95% CI, 0.61-0.91); this association did not differ by diabetes status (Pinteraction=0.07). There was a nominal difference by diabetes status for the association between cognitive impairment and kidney transplantation rate (Pinteraction=0.05), while the association between cognitive impairment and waitlist mortality differed by diabetes status kidney transplantation rates (Pinteraction=0.02). Among candidates without diabetes, those with cognitive impairment were at 2.47 (95% CI, 1.31-4.66) times greater risk for waitlist mortality; cognitive impairment was not associated with this outcome among candidates with diabetes. LIMITATIONS: Single measure of cognitive impairment. CONCLUSIONS: Cognitive impairment is associated with a lower chance of being placed on the waitlist, and among patients without diabetes, with increased mortality on the waitlist. Future studies should investigate whether implementation of screening for cognitive impairment improves these outcomes.
引用
- Chu NM, Shi Z, Haugen CE, et al. Cognitive Function, Access to Kidney Transplantation, and Waitlist Mortality Among Kidney Transplant Candidates With or Without Diabetes. Am J Kidney Dis. 2020. PMID: 32029264. doi:10.1053/j.ajkd.2019.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。